Eton Pharmaceuticals, Inc. Other Non-Current Liabilities
Eton Pharmaceuticals, Inc. (ETON) had Other Non-Current Liabilities of $3.94 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-13
- 2026-06-30: Other Liabilities, Noncurrent $3.94M.
- 2026-03-31: Other Liabilities, Noncurrent $3.54M.
- 2025-12-31: Other Liabilities, Noncurrent $5.24M.
- 2025-09-30: Other Liabilities, Noncurrent $3.94M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $3.94M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.54M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $5.24M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $3.94M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.27M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.15M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.83M 10-K · filed 2026-03-19 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |